针灸加运动疗法治疗偏瘫患者58例的疗效分析

目的：观察针灸疗法加运动治疗偏瘫患者的临床疗效，为提高偏瘫患者的治疗效果提供中医方法学的参考。方法本研究纳入本院2012年3月至2013年3月治疗的中风后偏瘫患者共110例，随机分为治疗组和对照组各55例，两组患者在入院后给予降低颅内压、神经营养、改善血流循环的药物治疗。治疗组在此基础上给予针灸加运动治疗。疗效评价结果包括基本恢复、显著进步、进步、稍进步、无变化、恶化（含死亡）。结果治疗组基本恢复8例，显著进步15例，进步18例，稍进步5例，无变化6例，恶化3例，治疗组的疗效等级显著较高。治疗后治疗组运动功能评分（FM A ）上肢为（41．5±7．2）分，FM A下肢为（28．9±7．9）分，与对照组比较差异有统计学意义（P＜0．05）。治疗组的Barthel指数为（72．9±10．2）分，显著高于对照组的（64．8±11．7）分。结论在传统治疗的基础上进行针灸治疗以及运动治疗，有助于减轻偏瘫患者脑细胞的病死率，值得在临床上推广使用。

Analysis of therapeutic effect of acupuncture plus exercise therapy for treatment of 58 cases of patients with hemiplegia

Objective To observe the clinical efficacy of acupuncture plus exercise therapy of hemiplegic patients ,in order to provide reference for treatment of hemiplegic patients .Methods This study included 110 cases of apoplectic hemiplegia patients in our hospital from March 2012 to March 2013 for treatment of ,and they were randomly divided into treatment group and control group with 55 cases in each group .Two groups of patients were given the treatment of reducing intracranial pressure ,improving blood circulation ,nerve nutrition drugs .The treatment group were given acupuncture plus exercise therapy .Efficacy evaluation results included the basic recovery ,significant progress ,progress ,a little progress ,no change ,deterioration（including death） .Results The treatment group had 8 cases recovered ,15 cases significant progressed ,18 cases progressed ,5 cases little progressed ,6 cases not changed , 3 cases deteriorated ,the effect grade was significantly higher in treatment group .After treatment ,FMA of upper limbs was（41 .5 ± 7 .2） ,and（28 .9 ± 7 .9）for FMA of lower limbs ,which were statistically significant different compared with those the control group（P〈0 .05） .The Barthel index of treatment group was （72 .9 ± 10 .2） ,which was significantly higher than control group of （64 .8 ± 11 .7） .Conclusion Acupuncture therapy and exercise therapy on the basis of the traditional treatment helps to reduce the death rate of brain cells in patients ,and it was worthy of promotion in clinical use .